BioCentury
ARTICLE | Company News

Chinese newco Brii launches with $260M

May 24, 2018 12:24 PM UTC

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on Thursday with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization and market access.

Arch, 6 Dimensions Capital and Boyu Capital led the round. Yunfeng Capital, Sequoia Capital and Blue Pool Capital also participated. ...

BCIQ Company Profiles

Vir Biotechnology Inc.